Market Research Blog

To remain ‘ahead’ of your competitors, request for a sample 

The top two companies in the global neurosurgery surgical power tools market hold over 56 percent share of the current market revenue and the remaining market share is controlled by tier-2 and tier-3 companies. The neurosurgery surgical power tools market showcases a highly consolidated landscape, leading to a high pricing premium of neurosurgery surgical power tools.

• A majority players in neurosurgery surgical power tools market are focusing on launching technologically advanced products expanded product portfolio.
• In addition, capacity expansion and emphasis on building strong distribution networkwill also be adopted as further growth strategies by the key players, according to FMI research.
• The companies are also focusing on introducing new products to strengthen the product portfolio in the developing markets of Asia Pacific to expand their clientele and grab maximum market share in the emerging economies.

“As per FMI analysis, the manufacturers of neurosurgery surgical power tools are also expected to gain from increasing regulatory approvals. Over the last few years, leading players have received regulatory approvals across major geographic markets, which has enabled them to launch various products in the market”, Senior Analyst, FMI.

Geographically, North America Reigns Supreme in Global Neurosurgery Surgical Power Tools Landscape

• North America and Europe represent a significant market share owing to higher install base, with an accumulative market share of approximately 64 percent.
• Asia Pacific, on the other hand is anticipated to present lucrative growth opportunities to neurosurgery surgical power tools manufacturers. The demand for neurosurgery surgical power tools in APAC is expected to grow at a moderate CAGR of 4.1 percent, through 2028.
• Rapid sophistication of the healthcare and medical sector in gulf economies is identified to be the key factor driving growth of MEA market.

FMI Identifies Key Trends Influencing Neurosurgery Surgical Power Tools Global Demand

• Paradigm shift from invasive to minimally-invasive surgeries considering lesser side effects compared to conventional surgeries. Reduced post-operative pain and hospital stay and faster recovery are few of the factors supplementing to the growth of minimally-invasive surgeries, particularly neurosurgical procedures.
• Another key trend identified is the automation of neurosurgery surgical power tools. The automated neurosurgical power tools are expected to increase the speed of cranial surgeries by almost 50 times compared to traditional techniques. Apart from reducing the procedure time from hours to minutes, such tools would also create lower risks of infection and damaging sensitive tissues.
• Demand for smaller sized and light weight power tools will dominate all the branches of neurosurgery, considering its ability to produce high speed and penetrate into deeper regions of brain.

“With the anatomical complexities associated with brain comes numerous risks associated with neurosurgery—a major growth deterrent. In addition, lack of neurosurgeons also pose a threat to the neurosurgery surgical power tools demand. According to most recent survey by the U.S. government, currently there is one neurosurgeon per 61,000 U.S. population—a ratio still inadequate to meet the current healthcare demands in the region. In developing markets like India, there are approximately 1,800 neurosurgeons (including about 25 women) for 1.27 billion people”, Senior Analyst, Future Market Insights

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8159

Competitive Landscape

The competition section of the report features profiles of key players operating in the neurosurgery surgical power tools market based on their market shares, product offerings, differential strategies, company dashboard and marketing approach.

Some of the key players featured in the neurosurgery surgical power tools market report are:

• Stryker Corporation
• ADEOR MEDICAL AG
• AYGUN CO., INC, B.
• Braun Melsungen AG
• De Soutter Medical
• Johnson & Johnson Services, Inc.
• ACRA-CUT Inc.
• KARL STORZ SE & Co. KG
• Medtronic plc.

The key manufacturers of neurosurgery surgical power tools focusing on new marketing strategies to expand their product penetration and geographical footprint in the global neurosurgery surgical power tools market.

Rise in prevalence of AIDS coupled with the increase in research & development (R&D) activities in proteomics field continues to drive adoption of western blotting industry. According to the report titled “Global HIV & AIDS Statistics- 2020 Fact Sheet” published by the UNAIDS Organization, 38 million people globally were living with HIV in 2019, while 75.7 million people have become infected with HIV since the start of the epidemic (end 2019). These data represent the unlimited opportunities awaiting for suppliers and manufacturers in western blotting industry.

According to Future Market Insights (FMI), the global western blotting market is expected to expand at close to 6.0% CAGR during the forecast period of 2021 to 2031.

Key Takeaways from Study

• Electrophoresis blotting systems remain the preferred product type
• Surge in demand from pharmaceutical and biotechnology sectors to fuel sales of western blotting products
• Growing application in scientific research to favor stakeholders in western blotting industry
• US will remain the most lucrative market for western blotting globally
• Germany to maintain the lead in the world’s second largest western blotting market Europe
• Asia-Pacific to witness the fastest growth rate, while being led by China, India, and Japan
• The United Kingdom, France, Canada, Italy, and a few other countries remain lucrative for western blotting product manufactures

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1050

What are the Key Challenges Faced by Western Blotting Product Manufacturers?

Despite being highly required in molecular biology field and various other biotechnological research activities, western blotting products require complex life cycle during development phase. Also, manufacturing process of highly sought-after western blotting products such as automated dry blotting systems, chromogenic reagent kits, to name a few, requires costly laboratory set up, sufficient knowledge, and experts’ handling. These factors often work as constraints for small to medium manufacturing hubs and biotechnology institutes.

Also, the COVID-19 pandemic put a standstill to manufacturing of western blotting products due to scarcity of raw materials and labors during the long lock down period. Decline in key end-use industries such as scientific research, food & beverages, to name few, has further slowed down the growth of suppliers in the industry.

However, the potential of the western blotting industry is much higher than a few restraints, and manufacturers are giving best of their efforts to fully utilize the upcoming opportunities.

Western Blotting Market – Competitive Landscape

While the global western blotting industry is thriving on the top companies, the competition is getting stricter with each passing year. In order to secure their positions in the cut-throat competition, key Western Blotting Market. players are focusing on launching wider variety of products. For instance,

• Bio-Rad Laboratories, Inc. launched its new range of western blotting products such as Trans-Blot Turbo Transfer System, Immun-Blot PVDF Membrane, and others during the last 5 years from 2015 to 2020
• LI-COR, Inc. launched its new range of LI-COR Quantitative Western Blotting Solutions in 2020

Major key players providing western Market are-

• Thermo Fisher Scientific, Inc.
• GE Healthcare
• Hofmann-La Roche Ltd.
• Danaher Corporation (Lumigen, Inc.)
• EMD Millipore Corporation
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• LI-COR, Inc.
• Bio-Techne Corporation (ProteinSimple Inc.)
• Advansta, Inc.

The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1050

Western Blotting Market – Key Questions Answered in Report

• Which are the top companies operating in the Western Blotting Market?Some of the top companies providing western blotting solutions are Thermo Fisher Scientific, Inc., GE Healthcare, Bio-Rad Laboratories Inc., and LI-COR, Inc.
• Which are some of the lucrative markets for western blotting?The United States, The United Kingdom, Germany, China, India, Japan, and a few others are lucrative markets for western blotting, and are expected to dominate throughout the forecast period.
• Which is a highly sought-after product type for western blotting?Presently, electrophoresis blotting systems are the mostly sought-after in terms of product type, and are expected to keep leading over the forecast period as well.
• Which are some key applications of western blotting?Presently, research, diagnostic, and agricultural applications are key areas, while with advancements in the medical industry, manufacturers are subject to witness higher demand from these segments over the coming years.

Western Blotting Market Segmentation by Category

Product Type

• Electrophoresis Blotting Systems
  • Automated Dry Blotting Systems
  • Semi-Dry Blotting Systems
  • Traditional Wet Transfer Blotting Systems
• Reagent Kits
  • Chromogenic Reagent Kits
  • Chemiluminescent Reagent Kits
    • Horseradish Peroxidase (HRP) Substrate
    • Alkaline Phosphatase (AP) Substrate
  • Fluorescent Reagents
  • Antibodies
    • Primary Antibody
    • Secondary Antibody
  • Buffer Kits

Application

• Research
• Diagnostics
• Agricultural
• Food & Beverages
• Other Applications

End User

• Diagnostic Laboratories
• Research Institutions
• Pharmaceutical & Biotechnology Companies

Region

• North America
• Latin America
• Europe
• Middle East and Africa (MEA)
• East Asia
• South Asia
• Oceania

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1050

Efforts by governments and private health organizations to spread health awareness has resulted in increased focus towards solutions for early diagnostics for underlying conditions. Consequently, advances in wearables allows for real time data collection and analysis. This trend will aid in the expansion of product portfolios, while consolidating market position.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-826

Health and fitness applications are projected to display a relatively high rate of growth. Increasing expenditure by adults on leisure and sports activities are bolstering the demand for product such as the Fitbit. Advances in GPS tracking and Internet of Things will prove beneficial to market players.

The covid-19 pandemic has brought increased focus on healthcare, and market players are leveraging the crisis to promote their products to aid in analyzing potential patients. In addition, the growing importance of clinical mobility through smart watch devices is expected to gain traction with improvements to biosensor products.

On the other hand, market players will face challenges in the near future, affecting market expansion. High costs of purchasing wearable medical devices limits adoption rates. In addition, concerns over data security remains a challenge for manufacturers that will affect long term growth.

Key Takeaways from Wearable Medical Devices Market Study

• The global demand for wearable medical devices is expected to rise strongly, enabling the market to exhibit a CAGR of nearly 7% in the forecast period from 2021 to 2031.
• Therapeutic wearables will account for more than 50% of the market share owing to rising incidences of diabetes and respiratory disorders.
• Backed by rapidly increasing expenditure on the healthcare sector, the United States will account for major global market share.
• Increasingly favorable setups for reimbursement policies will play a key role in the growth of the U.K. market for wearables through 2021 and beyond.
• Germany will reflect high growth potential on the back of improvements to healthcare infrastructure, fueling demand for wearable medical devices.
• In the Asia Pacific excluding Japan region South Korea and China will emerge as lucrative markets supported by a large potential patient base.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-826

Wearable Medical Devices – Competitive Landscape

Leading players in the moderately consolidated wearable medical devices market are focused largely product development and strategic launches with the objective of improving on product differentiation, in addition to collaborations and acquisition in the industry for expertise and technology sharing processes.

In April 2021, Alvalux Medical, a Belgium based MedTech wearables producer announced the receipt of a second patent from the United States Patent and Trademark Office for its new ocular insert device, which is designed to provide users with home-based photo-biomodulation (PBM) therapy for the treatment of retinal ailments.

Also, 3M has announced the development of a new silicone adhesive material aimed towards application in wearable medical devices for improved comfort, with conformable and breathable characteristics, while also minimizing skin removal.

In March 2021, EOFlow a wearable drug delivery solution company announced the launch of a new smartphone application for integration with wearable insulin delivery devices, which has also received medical device approval for sales in South Korea.

Future Market Insights has also analyzed the following players in the wearable medical devices market in its detailed report

• Siemens AG
• Medtronic plc
• Bayer AG
• Fitbit Inc.
• Animas Corporation
• Panasonic Corporation
• Smiths Medical
• Johnson and Johnson
• A Smiths Group Company
• Owlet Baby Care
• Koninklijke Philips N.V.
• Hoffmann-La Roche Ltd.
• OMRON Corporation
• Rest Devices Inc.

This list is indicative – full details about the wearable medical devices market players are available upon request.

Key Segments

Product

• Wearable Monitoring and Diagnostic Devices
• Fetal and Obstetric Devices
  • Wearable Fetal Monitors
  • Infant Motion Sensing Monitors
• Continuous Glucose Monitoring Devices
• Cardiac Monitoring Devices
  • Wearable Heart Rate Monitors
  • Wearable Pulse Oximeters
  • Wearable Blood Pressure Monitors
• Wearable Therapeutic Medical Device
• Hearing Aid
• Insulin Pump
• Respiratory Therapy Devices
  • Sleep Apnea Devices
  • Non-invasive Ventilation
• Health and Fitness Devices

Application

• Patient Monitoring
• Home Healthcare
• Health and Fitness

Distribution Channel

• Hospital Pharmacies
• Clinics
• Online Channels
• Hypermarkets

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-826

Region

• North America (U.S. & Canada)
• Latin America (Mexico, Brazil, Argentina, Chile, Peru, & Rest of LATAM)
• Western Europe (Germany, U.K., France, Italy, Spain, BENELUX, Nordic, & Rest of W. Europe)
• Eastern Europe (Russia, Poland, CIS Countries and Rest of E. Europe)
• Middle East and Africa (GCC Countries, Turkey, South Africa, Israel, & Rest of MEA)
• Japan
• Asia Pacific excluding Japan (China, India, ASEAN, South Korea, Australia, & Rest of APEJ)

Adoption of hospital capacity management solutions is seen amongst large patient care facilities for rendering a smooth workflow in terms of downtime as well as cost. This factor is expected to drive the hospital capacity management solutions market in the forecast period.

Hospital Capacity Management Solutions Market Outlook & Key Findings

• Global hospital capacity management solutions market expected to grow at 5% CAGR through 2030
• RTLS (Real time locating system) preferred capacity management solution among end users
• Cloud-Based hospital capacity management solutions gaining adoption
• Manufacturers focusing on the introduction of integrated hospital capacity management solutions to have multiple solutions in one go
• North America and Europe collectively account for more than half of the hospital capacity management solutions market and would continue to do so during the forecast period

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1013

Key Takeaways of Hospital Capacity Management Solutions Market Study

• RTLS (Real time locating system) accounted for around 34% of hospital capacity management solutions market in 2019 and is expected to continue with being top-seeded in the forecast period
• Cloud-based hospital capacity management solution contributed for around 3/5th of market value share in 2019
• Cumulatively, North America and Europe contributed for more than 70% of the total share of the hospital capacity management solutions market in 2019
• Countries such as Brazil, China, South Africa, and India are expected to are emerging as lucrative markets, but pale in comparison to US and Europe

Expansive Prominence in the hospital capacity management solutions market

Taking the expansive way of growth helps in strengthening the solutions’ and software’s portfolio; as e-Health has picked up pace looking at the accuracy and need for data management.

• STANLEY Healthcare, in May 2020, announced the assimilation of AeroScout Real-Time Location System (RTLS) with certification from Cisco DNA Spaces. The objective of this move is to table economic solution across the healthcare industry
• Allscripts has its “2bPrecise” platform that takes in clinical information from the EHR preferred by client along with genomic/genetic data from the molecular labs, thereby giving a comprehendible patient record. This gives precise diagnoses at a faster rate.
• TeleTracking Technologies have their Capacity Management Suite with PreAdmitTracking with electronic bedboard to enable patient access as well as placement

Hospital Capacity Management Solutions Market: Segmentation

The global hospital capacity management solutions is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

• Workflow Management Solutions
• Asset Management Solutions
• Bed Management Solutions
• Quality Patient Care Solutions
• Real Time Locating System (RTLS)
• Event Driven Solutions
  • Online Registration Solutions
  • Attendance Management Tools
  • Event Driven Patient Tracking
  • Others

Application

• Standalone Solutions
• Integrated Solutions

Delivery Mode

• On Premise
• Cloud-Based

Regions

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1013

Key Takeaways of Contrast Media Injectors Market Study

• North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2020 and this trend is expected to continue during the forecast period
• Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
• AI is expected to speed up the process of injecting contrast media in the forecast period
• Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-823

Contrast Media Injectors Market Outlook & Key Findings

• Contrast media injectors market likely to grow at over 4.9 % through 2030
• The rising cost of contrast media injectors is expected to hamper the market growth as most small- and medium-sized hospitals cannot afford them
• Extensive research regarding biodegradable contrast media injectors to drive investment in the near future
• Unhealthy lifestyle to propagate the use of contrast media injectors in the upcoming period

Leading Players in Contrast Media Injectors Market

The contrast media injectors market players are trying out every possible mode of organic/inorganic growth to sustain themselves in the market. For instance – Windsong Radiology Group acquired MEDRAD Stellant FLEX Injection System to help both – Windsong and Bayer to avert downtime, standardize care, and minimize operational costs.

Shenzhen Anke High-tech Co. Ltd.’s single-head CT SCAN contrast media injector is endowed with injection interruption that facilitates flexible handling of emergencies. Contrast media injectors offered by Ulrich GmbH & Co. KG facilitate user-friendly handling and have been into the market since the last 3 decades with use in MRI and CT.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-823

The above-mentioned players along with the others in the contrast media injectors market include:

Americas

• Mallinckrodt (Guerbet SA)
• GE Healthcare

Europe

• Bayer AG
• Ulrich GmbH & Co. KG
• Bracco Imaging S.p.A
• Medtron

Asia Pacific

• Nemoto Kyorindo Co. Ltd
• Shenzhen Anke High-tech Co. Ltd

*The list is only for representational purposes not exhaustive. Full competitive intelligence with SWOT analysis available in the report

New Product Launches and Approval – The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

• In Apr 2020, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
• In Nov 2019, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
• In Aug 2019, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

According to Future Market Insights, the global automated suturing devices is poised to expand at a CAGR of 7.3% to reach a valuation of approx. US$ 473 million through 2021 and beyond.

Increasing research & development for advanced automated suturing devices due to the rising adoption of minimally invasive procedure is anticipated to accelerate the demand across countries such as U.S., Japan, India, China and UK.

Automated Suturing Devices Market Key Highlights from Report

• [257 Pages Report] How will the automated suturing devices market grow in the forecast period of 2021 and 2031?According to FMI, the global automated suturing devices market is poised to expand at over 7.3% CAGR between 2021 and 2031.
• Which is the most lucrative automated suturing devices market?According to FMI, North America is expected to be the most lucrative region over the forecast period of 2021-2031. Within North America, the U.S. is expected to account for maximum sales.
• Who is the leading end user of automated suturing devices?Hospitals are expected to emerge as the leading end user in the automated suturing devices market.
• Which are the prominent automated suturing devices market players?Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the global automated suturing devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-579

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market across Asia Pacific excluding Japan (APEJ).

Rising preference for automated suturing devices over conventional ones during laparoscopic surgery is a major factor for market growth. Furthermore, the device is also preferred by procurement teams at hospitals as it’s labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Thereby, improving the market growth.

Major Key Companies Profiled:

• Medtronic Plc.
• Boston Scientific
• C. R. Bard, Inc.
• Apollo Endosurgery
• EndoEvolution, LLC
• LSI Solutions, Inc.
• SuturTek Inc.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

• By product type, disposable automated suturing devices to emerge as lucrative segment through 2021
• Increasing application in minimally invasive surgeries to stimulate suturing devices sales
• The U.S. is expected to experience noteworthy expansion amid robust presence of regional suture devices manufacturers, experiencing 1.9x growth
• India and China are expected to offer lucrative opportunities across South Asia & East Asia
• Japan is expected to register a stellar growth on the back of rising adoption of minimally invasive procedures
• Growing cases of gastrointestinal diseases to widen automated suturing devices adoption across Germany

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-579

Competitive Landscape

Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the automated suturing devices market.

Product development and innovation of new devices coupled with strategic mergers and acquisition remains the core strategy for the leading players to maintain a strong foothold in the industry.

In December 2019, for instance, a global leading player, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, another leading player, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.

Furthermore, in June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for Over Stitch Sx Endoscopic Suturing System. The endoscopic suturing systems allowed physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.